Biocon Limitedfounded In 1978 By Kiran Mazumdar Shaw In Bangaloreindiahas Evolved Into A Global Leader In Biopharmaceuticalsinitially Starting As A Joint Venture Focused On Enzyme Manufacturingthe Company Now Employs Over 12 000 People And Operates In More Than 120 Countriesbiocon Made History As The First Indian Firm To Receive U Sfda Approval For Its Lovastatin Api In 2001 The Company Specializes In A Range Of Productsincluding Biopharmaceuticals For Diabetes And Oncologyas Well As Biosimilars Like Hertraz And Kisqalibiocon Has Also Partnered With Viatris To Commercialize Insulin Analogs Globallywith A Commitment To Providing Affordable Therapiesbiocon Serves Healthcare Providers And Patients In Developed Marketsemphasizing Access To Treatments For Chronic Diseases
